BioSpyder to Exhibit at AACR Annual Meeting 2026

BioSpyder to Exhibit at AACR Annual Meeting 2026 
April 19–22, 2026 | American Association for Cancer Research Annual Meeting 

BioSpyder is excited to be exhibiting at the 2026 AACR Annual Meeting from Sunday, April 19 through Wednesday, April 22. We look forward to connecting with cancer researchers, translational scientists, and industry leaders to discuss how TempO-Seq is advancing gene expression profiling with streamlined workflows and powerful transcriptomic insights. 

AACR is an important opportunity to engage with the global cancer research community and highlight how BioSpyder’s technologies support discovery across oncology and translational research. This year, we are especially excited to showcase TempO-Seq Dried Blood Spot, which may be particularly impactful for AACR attendees interested in non-invasive sample types and high-quality transcriptomic data generation. 

Visit us at booth 2157 to learn more about how TempO-Seq and TempO-Seq DBS can support your cancer research. 

About BioSpyder 
  

BioSpyder is a leading provider of advanced molecular biology technologies, committed to expanding scientific capabilities in toxicology, cancer biology, and environmental health. The company's TempO-Seq platform and related approaches continue to shape the landscape of genomics research, facilitating breakthroughs in drug discovery, translational research, and diagnostics.   

#AACR2026 #AACR #CancerResearch #TranslationalResearch #GeneExpression #Transcriptomics #BioSpyder #TempOSeq #DBS